Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery
Da Sun, Zheng‐Rong Lu
Pharmaceutical Research (2023) Vol. 40, Iss. 1, pp. 27-46
Open Access | Times Cited: 119
Extracellular vesicles: The next generation in gene therapy delivery
Riccardo Cecchin, Zach Troyer, Ken Witwer, et al.
Molecular Therapy (2023) Vol. 31, Iss. 5, pp. 1225-1230
Open Access | Times Cited: 99
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 95
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 74
Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 66
Outlook of pandemic preparedness in a post-COVID-19 world
B. Adam Williams, Charles H. Jones, Verna Welch, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Approved Nanomedicine against Diseases
Yuanchao Jia, Yuxin Jiang, Yonglong He, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 774-774
Open Access | Times Cited: 62
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 60
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
Yaru Jia, Xiu‐Guang Wang, Luwei Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 56
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 53
Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles
Muskan Muskan, Pevindu Abeysinghe, Riccardo Cecchin, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2939-2949
Closed Access | Times Cited: 39
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy
Xueqiang Peng, Jianjun Fang, Chuyuan Lou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3432-3456
Open Access | Times Cited: 23
Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospect
Tianjiao Wang, Youhong Tang, Yuandong Tao, et al.
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 19
IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation
Caitlin M. Tilsed, Barzan A. Sadiq, Tyler E. Papp, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 18
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects
Serena Omo‐Lamai, Yufei Wang, Manthan N. Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 18
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Carole Fournier, Marion Mercey-Ressejac, Valentin Dérangère, et al.
EBioMedicine (2025) Vol. 112, pp. 105543-105543
Open Access | Times Cited: 2
Revolutionizing Drug Delivery: The Impact of Advanced Materials Science and Technology on Precision Medicine
Mohamed El‐Tanani, Shakta Mani Satyam, Syed Arman Rabbani, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 375-375
Open Access | Times Cited: 2
Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: Mechanistic challenges, delivery strategies, and therapeutic applications
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124582-124582
Open Access | Times Cited: 34
An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109934-109934
Open Access | Times Cited: 28
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Hanjin Seo, Leekang Jeon, Jaeyeong Kwon, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Closed Access | Times Cited: 25
Protein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation
Maharshi Debnath, James Forster, Anujan Ramesh, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 10, pp. 1766-1779
Closed Access | Times Cited: 25
The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism
Daria M. Strelkova Petersen, Namit Chaudhary, Mariah L. Arral, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 126-135
Open Access | Times Cited: 25
Nucleic acid-based drugs for patients with solid tumours
Sebastian G. Huayamares, David Loughrey, Hyejin Kim, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 407-427
Closed Access | Times Cited: 15
Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
Fei Wang, Cai Guang, Yingchao Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top